Publications by authors named "Michal Laufer Perl"

Claim this Profile
M
Mildly elevated left ventricular outflow tract gradients are associated with increased short-term mortality in inpatients without septal hypertrophy.
Moran Gvili Perelman, Michal Laufer-Perl, Ariel Banai, Ido Avivi, Yacov Shacham

Int J Cardiol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Localized abnormal Q waves are not associated with echocardiographic regional wall motion abnormalities.
Yoav Granot, Tal Ben Shaul, Shir Frydman, Michal Laufer Perl, Shmuel Banai

Heart Rhythm· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Mechanics in Heart Failure With Preserved Ejection Fraction: Effect of a No-Implant Interatrial Shunt.
Michal Laufer-Perl, Nir Flint, Yaron Arbel, Fawaz Alenezi, Veraprapas Kittipibul

Circ Heart Fail· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary implementation of guideline-directed medical and device therapies in heart failure: Insights from the Central/Eastern Europe Quality of Care Centres Survey.
Petar M Seferović, Marija Polovina, Jan Krejči, Bela Merkely, Mariya Tokmakova, Michal Laufer-Perl

Eur J Heart Fail· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of coronary artery calcium deposit for cardiovascular events in patients treated with immune checkpoint inhibitors.
Moaad Slieman, Ophir Freund, Galit Aviram, Haim Shmilovich, Zach Rozenbaum, Michal Laufer-Perl

Cardiooncology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Management of Elevated Troponin Level in Patients Treated with Immune Checkpoint Inhibitors.
Lior Zornitzki, Dana Viskin, Ophir Freund, Ido Wolf, Anna Rozenfeld Hemed, Michal Laufer-Perl

CJC Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune checkpoint inhibitor-associated myocarditis: a novel risk score.
John R Power, Charles Dolladille, Benay Ozbay, Adrien Procureur, Stephane Ederhy, Michal Laufer-Perl

Eur Heart J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive value of serial troponin measurements in patients treated with immune checkpoint inhibitors.
Moran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, Yasmin Leshem, Ari Raphael, Michal Laufer-Perl

Oncologist· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of recurrent heart failure hospitalizations and mortality using the echocardiographic Killip score.
Yoav Granot, Yuval Meir, Michal Laufer Perl, Assi Milwidsky, Ben Sadeh

Clin Res Cardiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitor Myocarditis and Left Ventricular Systolic Dysfunction.
Yen-Chou Chen, Charles Dolladille, Anjali Rao, Nicolas L Palaskas, Anita Deswal, Michal Laufer-Perl

JACC CardioOncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of echocardiographic-derived stroke volume in severe primary mitral regurgitation.
Yoav Granot, Sheizaf Gefen, Daniel Karlsberg, Orly Ran Sapir, Michal Laufer Perl

Eur Heart J Cardiovasc Imaging· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of immune checkpoint inhibitors in patients with pre-treatment reduced left ventricular function.
Maor Tzuberi, Rafael Y Brzezinski, Nir Flint, Moaad Slieman, Lior Zornitzki, Michal Laufer-Perl

Cardiooncology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interatrial Shunt Treatment for Heart Failure: The Randomized RELIEVE-HF Trial.
Gregg W Stone, JoAnn Lindenfeld, Josep Rodés-Cabau, Stefan D Anker, Michael R Zile, Michal Laufer-Perl

Circulation· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A perfect mimic: the role of multimodality imaging in right ventricular cardiomyopathy-a case report.
Dana Viskin, Michal Laufer-Perl, Yan Topilsky, Shmuel Banai, Shafik Khoury

Eur Heart J Case Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo fluid dynamics of the Ventura interatrial shunt device in patients with heart failure.
Michael Pfeiffer, John Boehmer, John Gorcsan, Shunsuke Eguchi, Yoshiyuki Orihara, Michal Laufer Perl

ESC Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial Mechanics, Atrial Cardiomyopathy and Impact of Atrial Interventions.
Veraprapas Kittipibul, Michal Laufer-Perl, Kathir Balakumaran, Maria Rosa Costanzo, Thomas H Marwick

J Card Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Inflammation in Early Left Ventricular Thrombus Formation Following ST-Elevation Myocardial Infarction-A Matched Case-Control Study.
Batia Litmanowicz, Moran Gvili Perelman, Michal Laufer-Perl, Yan Topilsky, Shmuel Banai

Clin Cardiol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine Ankle-Brachial Index (ABI) measurement: a window into atherosclerosis and early left ventricular dysfunction in patients diagnosed with cancer.
Netanel Golan, Rafael Y Brzezinski, Moaad Slieman, Shafik Khoury, Ofer Havakuk, Michal Laufer-Perl

Cardiooncology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise limitation in hypertrophic cardiomyopathy: combined stress echocardiography and cardiopulmonary exercise test.
Yonatan Erez, Eihab Ghantous, Aviel Shetrit, Ryan S Zamanzadeh, David Zahler, Michal Laufer Perl

ESC Heart Fail· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-related differences in the association between septal wall thickness and survival.
Shafik Khoury, Lior Zornitzki, Michal Laufer-Perl, Raghav T Bhatia, Sarandeep Marwaha

Int J Cardiol Heart Vasc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity.
John R Power, Charles Dolladille, Benay Ozbay, Adrien Md Procureur, Stephane Ederhy, Michal Laufer-Perl

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.
Josep Rodés-Cabau, JoAnn Lindenfeld, William T Abraham, Michael R Zile, Saibal Kar, Michal Laufer Perl

Eur J Heart Fail· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of combined non-severe aortic stenosis and mitral regurgitation on clinical outcomes: a single-centre retrospective study.
Yoav Granot, Orly Ran Sapir, Michal Laufer-Perl, Dana Viskin, Shmuel Banai

BMJ Open· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab.
Yasmin Leshem, Tal Etan, Yardenna Dolev, Alla Nikolaevski-Berlin, Mor Miodovnik, Michal Laufer-Perl

Int J Cardiol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors.
Moran Gvili Perelman, Rafael Y Brzezinski, Barliz Waissengrin, Yasmin Leshem, Or Bainhoren, Michal Laufer-Perl

Cardiooncology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis